Vivien Corp (002070) — Free Cash Flow Generation Index

Latest as of June 2025: 0.93x

Vivien Corp (002070) has a Free Cash Flow Generation Index of 0.93x as of June 2025. Free cash flow of ₩4.67 Billion represents 1% of operating cash flow (₩5.03 Billion). Read 002070 current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.93x
Free Cash Flow / Operating CF

Free Cash Flow

₩4.67 Billion
KRW

Operating Cash Flow

₩5.03 Billion
KRW

Capital Expenditures

₩357.45 Million
KRW

Vivien Corp Free Cash Flow Generation Index (2002–2025)

Historical FCF Generation Index trend for Vivien Corp across 13 annual periods. Explore 002070 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Vivien Corp (2002–2025)

Year-by-year Free Cash Flow Generation Index for Vivien Corp. For the full company profile including market capitalisation, see market cap of Vivien Corp.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2025 0.73x ₩6.30 Billion ₩8.61 Billion ₩2.31 Billion ▲ +3025.8%
2023 0.02x ₩30.18 Million ₩1.29 Billion ₩1.26 Billion ▲ +100.9%
2020 -2.55x ₩-8.35 Billion ₩3.27 Billion ₩11.54 Billion ▼ -374.4%
2019 0.93x ₩12.33 Billion ₩13.26 Billion ₩887.61 Million ▲ +391.8%
2018 -0.32x ₩-240.31 Million ₩754.44 Million ₩955.57 Million ▼ -114.6%
2010 2.18x ₩15.13 Billion ₩6.93 Billion ₩8.21 Billion ▲ +3.9%
2009 2.10x ₩9.88 Billion ₩4.70 Billion ₩5.18 Billion ▼ -62.3%
2008 5.58x ₩16.15 Billion ₩2.89 Billion ₩13.26 Billion ▲ +234.8%
2007 1.67x ₩5.00 Billion ₩3.00 Billion ₩2.00 Billion ▲ +35.2%
2006 1.23x ₩18.04 Billion ₩14.63 Billion ₩3.41 Billion ▼ -15.3%
2005 1.46x ₩26.74 Billion ₩18.36 Billion ₩8.38 Billion ▼ -62.2%
2004 3.85x ₩7.94 Billion ₩2.06 Billion ₩5.88 Billion ▲ +32.8%
2002 2.90x ₩16.55 Billion ₩5.71 Billion ₩10.83 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).